Stock screener

RGNX

Conviction 20HealthcareScan · Thu, Sep 24, 2026

REGENXBIO Inc. (RGNX) closed at $7.23 (-3.60%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 32, RS Rating 28, -54.8% from its 52-week high, -46.7% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

RGNX$7.23-3.60%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
Vol MA14 1.46M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
REGENXBIO Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.regenxbio.com ↗
Price7.23
Change-3.60%
Gap-1.27%
Rel volume2.00×
Avg volume1.36M
Avg $ vol11.49M
SMA 208.59
SMA 509.62
SMA 20010.05
Price vs 50-24.87%
Price vs 200-28.08%
MA stackbearish
50/200 crossdeath · 4d
Supertrenddown · 8.92
RSI (14)32
MACD hist-0.07
MACD cross—
Stoch %K / %D5 / 12
ADX (14)21
+DI / −DI16 / 35
RSI divergenceBullish
MACD divergenceBullish
ATR %8.15%
ADR %5.60%
52w high15.98
52w low5.65
From 52w high-54.76%
Above 52w low+27.96%
New 52w highNo
SqueezeOff
Bollinger width32.38%
%B0.01
Donchian pos3.69%
Donchian high10.10
Donchian low7.12
AVWAP (52w high)9.39
vs AVWAP high-23.00%
AVWAP (52w low)9.56
vs AVWAP low-24.36%
OBV trendDown
Chaikin MF (20)-0.21
Today vs 20d2.00×
Avg vol (14d)1.46M
Avg vol (20d)1.36M
Avg $ vol (20d)11.49M
Market cap477.28M
RS Rating28 / 99
RS 3m (vs SPY)-33.89%
RS 6m (vs SPY)-31.36%
RS line new highNo
Trend template0/8
Technical rank12.9
1 week-11.99%
1 month-18.86%
3 months-29.39%
6 months-14.54%
1 year-19.04%
YTD-46.72%
P/E-2.46
P/B6.65
P/S2.80
P/FCF-3.78
EPS-3.76
Div yield—
ROE-270.16%
ROA-50.15%
Debt/Eq—
Current2.86
EV/EBITDA-3.03
Gross margin—
Net margin-113.75%
Rev growth104.54%
EPS growth14.63%
Price target22.00
Target upside204.29%
Analyst ratingBuy
Institutional69.36%
Ent. value440.79M
Revenue108.02M
Net income22.71M
Gross profit—
Free cash flow-126.38M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out51.7M
Employees371
ListedThu, Sep 17, 2015
Free float38.66M
Float %74.9%
Short interest7.5M
Days to cover4.9d
Short volume56.7%
Squeeze score89 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.43 vs $0.12
Last surprise+258.3% beat
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank12.9 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance11.79
Support7.70
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in RGNX

All disclosures →
No recent disclosed trades by Congress in RGNX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RGNX · open-market 2 buys

InsiderSideShares
Ciongoli Gregory Austin
Director · Common Stock · 2026-08-27
Buy53.41K
Ciongoli Gregory Austin
Director · Common Stock · 2026-08-26
Buy49.2K
Ciongoli Gregory Austin
Director · Common Stock · 2026-08-25
Grant15.43K
Ciongoli Gregory Austin
Director · Stock Options (Right to buy) · 2026-08-25
Grant69.61K
Glucksmann Alexandra
Director · Stock Options (Right to Buy) · 2026-05-29
Grant46.6K
KARABELAS ARGERIS N
Director · Common Stock · 2026-05-29
Grant9.81K
Glucksmann Alexandra
Director · Common Stock · 2026-05-29
Grant9.81K
Tasse Daniel
Director · Stock Options (Right to Buy) · 2026-05-29
Grant46.6K
Zachary Jennifer
Director · Common Stock · 2026-05-29
Grant9.81K
KARABELAS ARGERIS N
Director · Stock Options (Right to Buy) · 2026-05-29
Grant46.6K

SEC filings

EDGAR filings in RGNX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.